Condition
Peritoneal Dialysis Patients
Total Trials
4
Recruiting
0
Active
0
Completed
2
Success Rate
100.0%+13% vs avg
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 40/100
Termination Rate
0.0%
0 terminated out of 4 trials
Success Rate
100.0%
+13.5% vs benchmark
Late-Stage Pipeline
25%
1 trials in Phase 3/4
Results Transparency
0%
0 of 2 completed with results
Key Signals
100% success
Data Visualizations
Phase Distribution
3Total
Not Applicable (2)
P 3 (1)
Trial Status
Completed2
Unknown1
Enrolling By Invitation1
Trial Success Rate
100.0%
Benchmark: 86.5%
Based on 2 completed trials
Clinical Trials (4)
Showing 4 of 4 trials
NCT06842927Enrolling By Invitation
Dialysis Efficiency and Transporter Evaluation Computational Tool in Peritoneal Dialysis
NCT03773029Not ApplicableUnknownPrimary
The Effects of Isoflavones on Cardiovascular and Bone Metabolism Markers in Peritoneal Dialysis Patients
NCT03367000Not ApplicableCompletedPrimary
Protein Supplementation In Dialysis Patients
NCT00433849Phase 3CompletedPrimary
Clinical Study of R744 to Peritoneal Dialysis Patients
Showing all 4 trials